---
title: big data in healthcare
videoId: eHJXh5zvOHU
---

From: [[foundmyfitness]] <br/> 

Dr. Michael Snyder, Chair of the Department of Genetics and Director of the Center for Genomics and Personalized Medicine at Stanford, leads a team of over 100 scientists at the Innovation Lab at Stanford <a class="yt-timestamp" data-t="00:00:05">[00:00:05]</a>. His research aims to transform healthcare from a treatment-focused system to one that emphasizes prevention in addition to treatment <a class="yt-timestamp" data-t="00:00:21">[00:00:21]</a>. He is also the founder of Q Bio, a company that gathers extensive health data for individuals <a class="yt-timestamp" data-t="00:00:35">[00:00:35]</a>, and January AI, a glucose monitoring company <a class="yt-timestamp" data-t="00:00:42">[00:00:42]</a>.

Inspired by William Thompson's quote, "If you can't measure it, you can't improve it," Dr. Snyder's work is centered on the principle that more information is always better than less <a class="yt-timestamp" data-t="00:01:20">[00:01:20]</a>. He himself is one of the most extensively monitored individuals, collecting data from various parameters <a class="yt-timestamp" data-t="00:01:34">[00:01:34]</a>.

## The "Big Data" Approach

Dr. Snyder's research involves [[deep_profiling_and_personalized_medicine | deep molecular measurements]] on individuals, including <a class="yt-timestamp" data-t="00:02:02">[00:02:02]</a>:
*   **DNA Sequencing**: To identify genetic risk factors <a class="yt-timestamp" data-t="00:02:06">[00:02:06]</a>.
*   **Blood and Urine Profiling**: Measuring literally tens of thousands of molecules <a class="yt-timestamp" data-t="00:02:18">[00:02:18]</a>.
*   **Microbiome Analysis**: Studying stool samples for the [[gut_microbiome_health_and_its_impact_on_overall_health | microbiome]] composition <a class="yt-timestamp" data-t="00:02:24">[00:02:24]</a>.
*   **Wearables**: Utilizing smartwatches and other devices for continuous monitoring of physiological data <a class="yt-timestamp" data-t="00:02:26">[00:02:26]</a>.

This comprehensive data collection aims to create a "1,000-piece picture" of an individual's health, as opposed to the "5 pieces" typically obtained in traditional medical check-ups <a class="yt-timestamp" data-t="00:18:37">[00:18:37]</a>. By profiling people deeply and over time, researchers can observe shifts from individual baselines, which is critical for understanding health <a class="yt-timestamp" data-t="00:19:02">[00:19:02]</a>.

## Personalized Health Insights

### Early Disease Detection: Type 2 Diabetes
Dr. Snyder's genome sequence surprisingly indicated a risk for type 2 diabetes, despite him not being overweight or having a family history <a class="yt-timestamp" data-t="00:02:59">[00:02:59]</a>. By tracking his sugar levels, he discovered his glucose shooting up nine months after his DNA sequencing, leading to a diagnosis of type 2 diabetes <a class="yt-timestamp" data-t="00:03:26">[00:03:26]</a>. This condition was triggered by a nasty viral infection, a finding relevant to the current pandemic where COVID-19 is thought to trigger type 2 diabetes <a class="yt-timestamp" data-t="00:04:38">[00:04:38]</a>.

The use of continuous glucose monitors (CGMs) has revealed that 9 out of 10 people with pre-diabetes are unaware of their condition <a class="yt-timestamp" data-t="00:05:30">[00:05:30]</a>. CGMs, while still medical devices, are becoming more accessible through companies like NutriSense, January.AI, and Levels <a class="yt-timestamp" data-t="00:07:04">[00:07:04]</a>. These devices are crucial for identifying individuals whose glucose levels are starting to go out of control, even if they appear healthy <a class="yt-timestamp" data-t="00:05:36">[00:05:36]</a>.

### Personalized Glucose Regulation
Glucose levels are typically below 90 mg/dL, with over 120 mg/dL classified as type 2 diabetic, and the range in between as pre-diabetes <a class="yt-timestamp" data-t="00:07:37">[00:07:37]</a>. Continuous glucose monitors show that individuals spike differently to various foods; for example, Dr. Snyder's glucose spikes to over 350 mg/dL after eating pulled pork due to hidden sugar <a class="yt-timestamp" data-t="00:08:12">[00:08:12]</a>. This individual variability, partly attributed to the [[gut_microbiome_health_and_its_impact_on_overall_health | microbiome]], highlights the need for personal measurements to understand one's unique metabolic responses <a class="yt-timestamp" data-t="00:08:41">[00:08:41]</a>.

Dr. Snyder believes everyone should wear a CGM <a class="yt-timestamp" data-t="00:09:45">[00:09:45]</a>. These monitors help pre-diabetics discover their glucose spikes and allow even healthy individuals to personalize their habits based on how different foods affect them <a class="yt-timestamp" data-t="00:09:59">[00:09:59]</a>. For instance, a brisk walk 15 minutes after eating white rice can significantly suppress glucose spikes <a class="yt-timestamp" data-t="00:15:53">[00:15:53]</a>.

### Diabetes: More Than Just Type 1 or Type 2
Dr. Snyder suggests that diabetes is likely 50 different diseases, not just type 1 or type 2 <a class="yt-timestamp" data-t="00:10:27">[00:10:27]</a>. His own case demonstrates this: he is insulin-sensitive and produces insulin, but his pancreas does not release it properly <a class="yt-timestamp" data-t="00:12:11">[00:12:11]</a>. This specific diagnosis means he doesn't respond to common type 2 diabetes drugs like metformin but benefits greatly from repaglinide, which promotes insulin release <a class="yt-timestamp" data-t="00:12:28">[00:12:28]</a>. This highlights the power of [[deep_profiling_and_personalized_medicine | deep profiling]] for tailored therapies <a class="yt-timestamp" data-t="00:12:45">[00:12:45]</a>.

## Longitudinal Data Collection and Discoveries
Current healthcare often measures very little when people are healthy, leading to a broken system <a class="yt-timestamp" data-t="00:17:35">[00:17:35]</a>. By collecting a vast amount of data (RNA, proteins, metabolites, lipids, microbiome), researchers gain a more complete health picture <a class="yt-timestamp" data-t="00:18:09">[00:18:09]</a>.

Key findings from Dr. Snyder's study of 109 individuals over three years include <a class="yt-timestamp" data-t="00:20:13">[00:20:13]</a>:
*   **Individual Baselines**: Everyone's molecular profile is unique and remains relatively stable over time <a class="yt-timestamp" data-t="00:19:15">[00:19:15]</a>.
*   **Detecting Shifts**: When a person gets sick, their profile shifts, but they still resemble their healthy baseline more than anyone else's <a class="yt-timestamp" data-t="00:19:39">[00:19:39]</a>. This makes early detection of shifts crucial <a class="yt-timestamp" data-t="00:20:06">[00:20:06]</a>.
*   **Early Disease Discovery**: Nearly half of the participants (49 out of 109) learned something important about their health, often before symptoms appeared <a class="yt-timestamp" data-t="00:20:21">[00:20:21]</a>.
    *   Examples include early lymphoma, pre-cancers (MGUS, smoldering myeloma), serious heart issues, and undiagnosed diabetes <a class="yt-timestamp" data-t="00:20:32">[00:20:32]</a>.
*   **Integrated Technologies**: No single technology was responsible; rather, the combination of genome sequencing, protein markers, and imaging provided a holistic view <a class="yt-timestamp" data-t="00:21:02">[00:21:02]</a>.

This [[exponential_technologies_and_health_advancements | big data]] [[biomarkers in health monitoring | profiling]] is powerful for catching diseases early, preventing major health events like heart attacks <a class="yt-timestamp" data-t="00:21:41">[00:21:41]</a>.

### Transitioning to Precision Medicine
While Dr. Snyder's initial work is research, the goal is to translate these findings into scalable medical applications. The company Q Bio offers a medical version of this deep profiling, including molecular measurements and whole-body MRIs, costing around $3,500 <a class="yt-timestamp" data-t="00:22:31">[00:22:31]</a>.

However, challenges remain:
*   **Incentives**: The U.S. healthcare system typically pays when people are ill, not to keep them healthy <a class="yt-timestamp" data-t="00:23:16">[00:23:16]</a>. Re-incentivizing employers or showing economic benefits for insurers (e.g., preventing expensive long-term disability from heart attacks) could drive change <a class="yt-timestamp" data-t="00:23:35">[00:23:35]</a>.
*   **Physician Adoption**: Many physicians are resistant to deep profiling, fearing it could overwhelm the system or make people hypochondriacs <a class="yt-timestamp" data-t="00:24:42">[00:24:42]</a>. Dr. Snyder believes people are capable of handling this information to catch disease early <a class="yt-timestamp" data-t="00:25:11">[00:25:11]</a>.

## Wearables and Early Illness Detection
Wearables have evolved from fitness trackers to sophisticated physiological monitors, measuring heart rate, heart rate variability, skin temperature, respiration, blood oxygen, and even blood pressure <a class="yt-timestamp" data-t="00:26:36">[00:26:36]</a>. They collect hundreds of thousands, even millions, of measurements daily, providing a detailed view of physiology <a class="yt-timestamp" data-t="00:27:16">[00:27:16]</a>.

Dr. Snyder's personal experience with Lyme disease highlighted the power of wearables <a class="yt-timestamp" data-t="00:27:38">[00:27:38]</a>. His smartwatch and pulse oximeter showed abnormally low blood oxygen and high heart rate before he developed symptoms, allowing for early diagnosis and treatment <a class="yt-timestamp" data-t="00:28:35">[00:28:35]</a>.

Retrospective analysis of Dr. Snyder's data showed that his resting heart rate and skin temperature consistently rose before symptoms appeared in four instances of illness (Lyme, two viral infections, one asymptomatic illness) <a class="yt-timestamp" data-t="00:30:38">[00:30:38]</a>. This led to the development of algorithms that detect jumps in resting heart rate as an early indicator of illness <a class="yt-timestamp" data-t="00:30:50">[00:30:50]</a>.

This technology proved vital during the COVID-19 pandemic:
*   For 26 out of 32 COVID-19 patients wearing Fitbits, a jump in resting heart rate was detected at or before symptoms (81% of cases) <a class="yt-timestamp" data-t="00:32:25">[00:32:25]</a>.
*   On average, heart rate jumps approximately four days before COVID-19 symptoms <a class="yt-timestamp" data-t="00:32:56">[00:32:56]</a>.
*   The system can detect illness in real-time, alerting individuals based on sustained elevated resting heart rate <a class="yt-timestamp" data-t="00:33:13">[00:33:13]</a>. As of January, 70% of 63 COVID-19 cases were detected and alerted before or at the time of symptoms <a class="yt-timestamp" data-t="00:33:57">[00:33:57]</a>.

This detection is not specific to COVID-19 and can indicate other respiratory illnesses, though further algorithm refinement is needed to differentiate between causes (e.g., alcohol consumption vs. infection) <a class="yt-timestamp" data-t="00:34:17">[00:34:17]</a>. Individuals can participate in the COVID tracking study at innovations.stanford.edu/wearables <a class="yt-timestamp" data-t="00:34:54">[00:34:54]</a>.

Heart rate variability is another significant [[biomarkers in health monitoring | biomarker]] obtained from wearables <a class="yt-timestamp" data-t="00:35:36">[00:35:36]</a>. A variable heart rate is a sign of health, and these devices can even pick up conditions like atrial fibrillation (afib) and provide electrocardiogram (ECG) measurements <a class="yt-timestamp" data-t="00:36:04">[00:36:04]</a>.

## The Exposome
The "exposome" refers to all the things an individual is exposed to <a class="yt-timestamp" data-t="00:37:08">[00:37:08]</a>. Dr. Snyder's lab uses devices to measure airborne exposures, sucking up air and capturing particulates (pollen, bacteria, fungi) and chemicals (pesticides, plastics, carcinogens) <a class="yt-timestamp" data-t="00:37:11">[00:37:11]</a>.

The goal is to understand how environmental exposures contribute to disease, recognizing that disease risk depends on both genetics and environment <a class="yt-timestamp" data-t="00:38:21">[00:38:21]</a>. Environmental exposure has historically been poorly measured <a class="yt-timestamp" data-t="00:38:37">[00:38:37]</a>.

While controlling diet and exercise is straightforward, controlling airborne exposures is challenging <a class="yt-timestamp" data-t="00:38:47">[00:38:47]</a>. Air pollution is linked to increased risk for various [[aging_research_and_interventions | age-related diseases]], including Alzheimer's, even in children <a class="yt-timestamp" data-t="00:39:45">[00:39:45]</a>.

Studies have shown correlations between heavy metal mining upstream and high incidence of autoimmune disease along a river <a class="yt-timestamp" data-t="00:40:46">[00:40:46]</a>. Personal exposome data can lead to informed decisions; for instance, Dr. Snyder discovered his allergies correlated with eucalyptus, not pine, informing potential actions <a class="yt-timestamp" data-t="00:41:47">[00:41:47]</a>. The research aims to identify specific harmful molecules in the environment <a class="yt-timestamp" data-t="00:43:09">[00:43:09]</a>.

The lab is actively measuring exposures for firefighters and populations in high-pollution areas like Fresno, where there's a higher incidence of allergies and asthma <a class="yt-timestamp" data-t="00:44:03">[00:44:03]</a>. Research suggests compounds like sulforaphane (from broccoli sprouts) can increase the excretion of toxins like benzene, and activities like exercise and sauna bathing can promote the excretion of heavy metals like mercury through sweat <a class="yt-timestamp" data-t="00:45:16">[00:45:16]</a>.

## Ageotypes and Personalized Aging
By following individuals over time, Dr. Snyder's team observes how people are aging at a molecular level, rather than just comparing old and young populations <a class="yt-timestamp" data-t="00:48:03">[00:48:03]</a>. This has led to the concept of "ageotypes," which classify individuals based on their primary aging pathways <a class="yt-timestamp" data-t="00:49:19">[00:49:19]</a>.

Common ageotypes identified include:
*   **Metabolic ager** <a class="yt-timestamp" data-t="00:48:31">[00:48:31]</a>
*   **Kidney ager** <a class="yt-timestamp" data-t="00:48:31">[00:48:31]</a>
*   **Liver ager** <a class="yt-timestamp" data-t="00:48:31">[00:48:31]</a>
*   **Immune ager** <a class="yt-timestamp" data-t="00:48:31">[00:48:31]</a>
*   **Cardio ager** <a class="yt-timestamp" data-t="00:48:38">[00:48:38]</a>

Just as different parts of a car wear out first, individuals exhibit different patterns of aging <a class="yt-timestamp" data-t="00:48:50">[00:48:50]</a>. For example, a cardio ager was found to be stage two hypertensive <a class="yt-timestamp" data-t="00:49:01">[00:49:01]</a>.

These ageotypes provide actionable information <a class="yt-timestamp" data-t="00:50:07">[00:50:07]</a>:
*   A kidney ager might benefit from drinking more water <a class="yt-timestamp" data-t="00:50:55">[00:50:55]</a>.
*   A liver ager might reduce alcohol intake <a class="yt-timestamp" data-t="00:50:59">[00:50:59]</a>.
*   An immuno-ager might consider supplements like turmeric or garlic to boost their immune system <a class="yt-timestamp" data-t="00:51:05">[00:51:05]</a>.

This approach allows for measuring the effectiveness of interventions, including supplements, on individual aging rates <a class="yt-timestamp" data-t="00:51:52">[00:51:52]</a>. For example, some individuals showed decreasing creatinine (a marker of kidney function) while on statins, suggesting statins might improve kidney function <a class="yt-timestamp" data-t="00:50:16">[00:50:16]</a>.

While there's interest in "panaceas" like metformin to systematically slow [[aging_research_and_interventions | aging]], recent studies have shown that metformin can blunt exercise-induced benefits in healthy, physically active individuals <a class="yt-timestamp" data-t="00:52:54">[00:52:54]</a>. Exercise remains a cornerstone of [[Metabolic therapies in disease management | longevity]], boosting immune health, preventing sarcopenia (muscle loss), and remodeling muscle mass <a class="yt-timestamp" data-t="00:55:45">[00:55:45]</a>.

Aging is influenced by a combination of genetics and environmental/lifestyle factors <a class="yt-timestamp" data-t="00:58:41">[00:58:41]</a>. While genetics are harder to control, lifestyle factors like diet and exercise, and awareness of environmental exposures, offer avenues for intervention <a class="yt-timestamp" data-t="00:59:06">[00:59:06]</a>.

## Dr. Snyder's Lifestyle Routine
Dr. Snyder maintains an active lifestyle, exercising daily with weight training, which helped him gain 10 pounds of muscle mass <a class="yt-timestamp" data-t="00:59:45">[00:59:45]</a>. As a type 2 diabetic, he tries to avoid carbs and eats a lot of protein <a class="yt-timestamp" data-t="01:00:18">[01:00:18]</a>. He consciously incorporates fiber-rich foods like salads and carrots and supplements with fiber to reach the recommended daily intake <a class="yt-timestamp" data-t="01:00:33">[01:00:33]</a>. He also consumes nuts for omega-3s <a class="yt-timestamp" data-t="01:01:12">[01:01:12]</a>.

His [[gut_microbiome_health_and_its_impact_on_overall_health | microbiome]] remains relatively stable, requiring long-term commitment to shift, though antibiotics can cause temporary changes <a class="yt-timestamp" data-t="01:02:03">[01:02:03]</a>. Specific probiotics like *Lactobacillus reuteri* have shown personal benefits for Dr. Snyder <a class="yt-timestamp" data-t="01:02:28">[01:02:28]</a>. The lab is researching how different types of fibers affect the microbiome and health outcomes <a class="yt-timestamp" data-t="01:02:53">[01:02:53]</a>. For example, arabinoxylan from psyllium husk is known to lower cholesterol, possibly by promoting microbes that deal with bile acids to remove cholesterol from the blood <a class="yt-timestamp" data-t="01:03:37">[01:03:37]</a>.

While measuring personal microbiome composition is increasingly available through consumer companies, directly linking it to clinical value has been challenging <a class="yt-timestamp" data-t="01:05:55">[01:05:55]</a>. However, understanding the interplay between diet, the microbiome, and the immune system (given the high concentration of immune cells in the gut) is crucial for metabolic health and overall well-being <a class="yt-timestamp" data-t="01:07:04">[01:07:04]</a>.

Dr. Snyder's work emphasizes that [[big data in healthcare | big data]] provides a holistic understanding of health, moving beyond narrow views to create a complete picture <a class="yt-timestamp" data-t="01:07:42">[01:07:42]</a>. This approach aims to empower individuals to make healthy choices without relying solely on pharmaceuticals <a class="yt-timestamp" data-t="01:08:20">[01:08:20]</a>.

*To learn more about Dr. Snyder's work:*
*   Twitter: @SnyderShot <a class="yt-timestamp" data-t="01:09:11">[01:09:11]</a>
*   Stanford Innovation Lab: innovations.stanford.edu <a class="yt-timestamp" data-t="01:09:24">[01:09:24]</a>
*   COVID-19 Wearables Study: innovations.stanford.edu/wearables <a class="yt-timestamp" data-t="01:09:18">[01:09:18]</a>
*   Companies: January AI (glucose monitoring) <a class="yt-timestamp" data-t="01:09:32">[01:09:32]</a> and Q Bio (deep data profiling) <a class="yt-timestamp" data-t="01:09:39">[01:09:39]</a>